Sofosbuvir
P7977-1231
Phase 3 small_molecule completed
Quick answer
Sofosbuvir for Hepatitis C is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- Hepatitis C
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed